SCHEMBL9975442

SCHEMBL9975442

CC(O)C(C)C1(C)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12191506 0.73
SCHEMBL2345052 0.73
SCHEMBL12191508 0.73
SCHEMBL3149036 0.69
SCHEMBL12593588 0.69
SCHEMBL14050172 0.69
SCHEMBL3797017 0.65
SCHEMBL22013854 0.65
SCHEMBL12133368 0.65
SCHEMBL3003269 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157402-A1 METHODS FOR TREATING BRAIN TUMORS PTC THERAPEUTICS, INC. 2012-06-21 US disclosed
EP-1286682-B1 METHODS AND COMPOSITIONS FOR INHIBITING IMMUNOGLOBULIN-MEDIATED-REPERFUSION INJURY IMMUNE DISEASE INST INC (US) 2010-03-03 EP disclosed